Unknown

Dataset Information

0

Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.


ABSTRACT: Spliceostatin A (SSA) is a methyl ketal derivative of FR901464, a potent antitumor compound isolated from a culture broth of Pseudomonas sp no. 2663. These compounds selectively bind to the essential spliceosome component SF3b, a subcomplex of the U2 snRNP, to inhibit pre-mRNA splicing. However, the mechanism of SSA's antitumor activity is unknown. It is noteworthy that SSA causes accumulation of a truncated form of the CDK inhibitor protein p27 translated from CDKN1B pre-mRNA, which is involved in SSA-induced cell-cycle arrest. However, it is still unclear whether pre-mRNAs are uniformly exported from the nucleus following SSA treatment. We performed RNA-seq analysis on nuclear and cytoplasmic fractions of SSA-treated cells. Our statistical analyses showed that intron retention is the major consequence of SSA treatment, and a small number of intron-containing pre-mRNAs leak into the cytoplasm. Using a series of reporter plasmids to investigate the roles of intronic sequences in the pre-mRNA leakage, we showed that the strength of the 5' splice site affects pre-mRNA leakage. Additionally, we found that the level of pre-mRNA leakage is related to transcript length. These results suggest that the strength of the 5' splice site and the length of the transcripts are determinants of the pre-mRNA leakage induced by SF3b inhibitors.

SUBMITTER: Yoshimoto R 

PROVIDER: S-EPMC5159648 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.

Yoshimoto Rei R   Kaida Daisuke D   Furuno Masaaki M   Burroughs A Maxwell AM   Noma Shohei S   Suzuki Harukazu H   Kawamura Yumi Y   Hayashizaki Yoshihide Y   Mayeda Akila A   Yoshida Minoru M  

RNA (New York, N.Y.) 20161017 1


Spliceostatin A (SSA) is a methyl ketal derivative of FR901464, a potent antitumor compound isolated from a culture broth of Pseudomonas sp no. 2663. These compounds selectively bind to the essential spliceosome component SF3b, a subcomplex of the U2 snRNP, to inhibit pre-mRNA splicing. However, the mechanism of SSA's antitumor activity is unknown. It is noteworthy that SSA causes accumulation of a truncated form of the CDK inhibitor protein p27 translated from CDKN1B pre-mRNA, which is involved  ...[more]

Similar Datasets

2016-02-17 | E-GEOD-72156 | biostudies-arrayexpress
2016-02-17 | GSE72156 | GEO
| S-EPMC3428802 | biostudies-literature
| S-EPMC2410136 | biostudies-literature
| S-EPMC275466 | biostudies-literature
| S-EPMC6430687 | biostudies-literature
| S-EPMC4435825 | biostudies-literature
| S-EPMC4914122 | biostudies-literature
| S-EPMC3483155 | biostudies-literature
| S-EPMC3753360 | biostudies-literature